Guanfacine and Guanfacine Extended Release: Treatment for ADHD and Related Disorders

Guanfacine, an α(2A) adrenoceptor agonist, is U.S. Food and Drug Administration (FDA)–approved for the treatment of hypertension in adolescents and adults. It also has been used "off‐label" for several years in children as a possible treatment for attention‐deficit/hyperactivity disorder (...

Full description

Saved in:
Bibliographic Details
Published in:CNS Drug Rev
Main Authors: Posey, David J., McDougle, Christopher J.
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Inc 2007
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494159/
https://ncbi.nlm.nih.gov/pubmed/18078429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2007.00026.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items